As a potential compound targeting hyperpigmentation, KT‐939 demonstrates potent tyrosinase inhibition along with anti‐inflammatory and antioxidant properties, supporting its potential application in the treatment of melasma and other hyperpigmentation disorders, as well as its development as a whitening agent for cosmetic use. This evidence concerns the gene TYR and freckles.